- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Myeloma in Relapse in New Zealand
Total 839 results
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
Yale UniversityCompleted
-
Yale UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
University of RochesterTerminatedMultiple MyelomaUnited States
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
Tufts Medical CenterNational Cancer Institute (NCI)Not yet recruitingSmoldering Multiple MyelomaUnited States
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, Austria, Belgium, China, France, Hong Kong, Italy, Japan, Puerto Rico, Russian Federation, Spain, Switzerland, United Arab Emirates, United Kingdom, Kuwait, Saudi Arabia, Netherlands, Taiwan
-
ChimerixActive, not recruiting
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Genzyme, a Sanofi CompanyAnorMEDTerminatedMultiple MyelomaUnited States
-
Celularity IncorporatedCompleted
-
Seagen Inc.Terminated
-
Lava TherapeuticsActive, not recruitingAcute Myeloid Leukemia | Multiple Myeloma | Chronic Lymphocytic LeukemiaUnited States, Spain, France, Netherlands
-
AttenuonTerminated
-
Hackensack Meridian HealthJanssen, LPTerminatedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCCompletedMultiple MyelomaUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedMultiple MyelomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterColumbia University; Montefiore Medical Center; Weill Medical College of Cornell... and other collaboratorsCompleted
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminated
-
Sorrento Therapeutics, Inc.Active, not recruitingMultiple MyelomaUnited States
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; Fox Chase Cancer Center; GlaxoSmithKline and other collaboratorsCompletedMultiple MyelomaUnited States
-
Thomas Martin, MDSanofi; AmgenActive, not recruitingMultiple MyelomaUnited States, Canada
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Promontory Therapeutics Inc.CompletedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
University of NebraskaRecruiting
-
Astex Pharmaceuticals, Inc.Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
SkylineDxMedex15Active, not recruiting
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple Myeloma | Plasmacytoma | Plasmacytoma of BoneUnited States
-
Hackensack Meridian HealthCompletedMultiple Myeloma | Auto Stem Cell TransplantUnited States
-
Criterium, Inc.Celgene Corporation; AmgenTerminated
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
AbbottBristol-Myers SquibbTerminated
-
OncotherapeuticsAmgenUnknownMultiple MyelomaUnited States
-
Roswell Park Cancer InstituteCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Alkylating Agent-Related Acute Myeloid Leukemia | Refractory Anemia With Excess Blasts in TransformationUnited States
-
Astellas Pharma Global Development, Inc.Approved for marketingAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsUnited States, Canada, Japan
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Small Intestine Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Institut de Recherches Internationales ServierRecruitingMyelodysplastic Syndromes | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Untreated AML | Other IDH1-mutated Positive Hematologic MalignanciesUnited States, France